kras mutation and glutathion KRAS-targeted therapies in cancer: novel approaches overcoming resistance KRAS-Mutant Lung Cancer: Targeting Molecular

KRAS Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions PMC Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY Overcoming resistance to drugs targeting KRASG12C mutation Mechanisms of Resistance to KRAS Inhibitors: Cancer Cells' Strategic Use of Normal Cellular Mechanisms to Adapt Tanaka 2025 Cancer Science Wiley Online Library

SKU: 13220553382 · From reganhouse.co.nz